Total Length: 3144 words ( 10 double-spaced pages)
Total Sources: 14
Page 1 of 10
Abstract
This paper examines the impact of Parkinson’s disease on elderly (65+ years of age) Caucasian males. This is an underserved population in the U.S. 1% of all elderly persons suffer from Parkinson’s and 60% of them are of this underserved population. The paper discusses risk factors that may lead to the onset of this disease but recognizes that the etiology of Parkinson’s is still as of yet unknown. It examines some of the most common health issues of this population and identifies existing barriers to care. The key factors and social determinants of health of this population are discussed and health policies and advocacy groups, such as the Michael J. Fox Foundation are examined in terms of what they bring to the discussion about regulating control and prevention of the disease. Finally, recommendations for improving existing programs and interventions for this population are identified, including: the need to increase access to care by promoting the use of telemedicine, the need to focus on the impact that nutrition can have on preventing the disease, and the need to develop better interventions such as physical therapy, speech therapy and occupational therapy.
Keywords: parkinson’s elderly, parkinson’s Caucasian male elderly, preventing parkinson’s disease
Population
The population used for this study is elderly Caucasian males—white men over the age of 65. Approximately 60,000 Americans are diagnosed with Parkinson’s disease every year (Kowal, Dall, Chakrabarti, Storm & Jain, 2013). Almost 60% of these cases are amongst the elderly Caucasian male population (Dahodwala et al., 2009). The total number of patients suffering from Parkinson’s in the U.S. was estimated at 630,000 in 2010, but the prevalence of the disease is expected to double by the year 2040 based on the rising trend of cases over the recent years (Kowal et al., 2013). While the cause of Parkinson’s is unknown, the basic factors that contribute to the disease—the death of dopamine producing cells in the brain which leads to a loss of bodily control—is sufficiently understood to at least provide some possible treatments. A cure, however, has not yet been produced.
Risk factors include genetic makeup and environmental variables—and though it is not clear how the two work together it is believed that some connection between genes and one’s environment prompts the death of dopamine producing cells in the brain and triggers the onset of Parkinson’s. McCormack et al. (2002) have suggested with evidence that Parkinson’s is related to exposure to toxic pesticides that are commonly released into the environment, such as the herbicide paraquat. The results of their experiments with paraquat on in substantia nigra pars compacta showed a connection between the effect of pesticides on the brain and the characteristics of the onset of Parkinson’s. Satake et al. (2009) have identified genomic factors related to the onset of Parkinson’s, suggesting that it is possibly an inherited disease.
Most Prevalent Health Issues
The most common and prevalent health issues in the elderly (over 65 years of age) Caucasian male population are: 1) arthritis, 2) heart disease, 3) cancer, 4) respiratory disease, 5) Alzheimer’s, 6) osteoporosis, and 7) diabetes. Other health issues for this population include falls, pneumonia, obesity and depression (Jaul & Barron, 2017). Some of this health issues can be related to the onset of Parkinson’s—such as falls and depression (Farombi, Owolabi & Ogunniyi, 2016; Frisina, Borod, Foldi & Tenenbaum, 2008). Parkinson’s impacts 1% of the 65+ population, while approximately 10 times as many people suffer from arthritis. Parkinson’s disease impacts a high number of people but it is not as common as some of most prevalent problems that the elderly white male population suffers from. Arthritis, heart disease, cancer, respiratory disease and Alzheimer’s are among the most common.
Existing Access and Barriers to Health Care and Treatment Options
Treatment for this population can include a range of interventions, including medications such as dopamine promoters, antidepressants, anti-tremor drugs and cognition-enhancing medication. Self-care practices are also commonly used as a treatment, such as the use of a physical exercise program. Specialist medicine is also an option with neurologists and primary care providers offering suggestions determined on a case-by-case basis and the particular issues and symptoms that appear for each patient. As not every patient responds the same way to treatment and some may be impacted by correlating symptoms such as depression and anxiety while others may not be impacted by them, care providers have to assess patients individually.
Access to care for individuals with Parkinson’s disease, however, is very much based on the support network of the individual and may also be impacted by the individual’s socio-economic status. This is true for the elderly white male population as for any other population as well. As Parkinson’s disease is something that places the individual at a disadvantage in terms of mobility, the individual must typically rely on some form of support to seek treatment, whether that support comes from family, friends, or neighbors in a retirement community.
Access to care is available for those of the elderly white male population who seek it—however, barriers do also exist, depending on the extent to which the elderly white male is isolated, lives in a poor community or is too far from a facility that provides health care, or the extent to which the individual has not support network to rely upon for assistance, communication, transportation, help with treatment and so on.
As Dobkin et al. (2013) point out, Parkinson’s “is frequently complicated by co-occurring psychiatric problems, such as depression and anxiety, that negatively affect the course and management of the illness” (p. 105). However, the co-morbidity is rarely addressed or treated by health care providers. Instead, they focus only on the Parkinson’s problem and not on any of the attendant issues that may be related, such as issues of falling, anxiety and depression (Dobkin et al., 2013). One of the barriers to proper care, therefore, is negligence on the part of the health care community to properly provide a holistic approach to the treatment of patients with Parkinson’s. The main reason health care providers fail to provide holistic care is that they simply do not recognize the symptoms of mental health issues that correlate with Parkinson’s disease (Dobkin et al., 2013).
Another barrier is distance and time. Elderly white male patients suffering from Parkinson’s do not always have the means to travel to receive care, both because of the distance between themselves and a health care facility and the time that is required to make that trip. Elderly patients can tire frequently and become exhausted just making small trips. The need for multiple rests throughout the day can complicate any plans to receive care on a routine basis (Dorsey et al., 2013). Telemedicine is one way the care providers can help patients suffering from Parkinson’s to overcome obstacles of distance and time (Dorsey et al., 2013). The Michael J. Fox Foundation (2018) also advocates for the promotion of telemedicine to help bring the type of care that patients need to those who cannot physically overcome the obstacles of time and space to receive that care. Telemedicine is described as “the remote delivery of health care services and clinical information using telecommunications technology, including internet, cellular, wireless, satellite and telephone services” (Michael J. Fox Foundation, 2018). By using the technology available today, health care providers can reach the patients of tomorrow—including the elderly white male population.
Other access to care options for this population includes accessing government benefits such as Social Security, Medicaid, and disability services. This population may be able to apply for government aid for obtaining health care; however, Social Security is not as reliable as it once was, and Medicaid, too, has its limitations in terms of the extent of options one can obtain. In short, access to care is available—but it is also limited and not as full as it could be.
Key Factors/Social Determinants of Health Contributing to Overall Health Status of This Population
Key factors of health contributing to the overall health status of this population include lifestyle choices—such as diet, exercise, whether one drinks or smokes or abuses drugs; environmental factors such as community, socio-economic background, exposure to pollution or other toxins like pesticides over a prolonged period of time; and genetics, family medical history background. Members of the population who maintain healthy, organic diets and regularly exercise throughout their lives have fewer problems in their elder years than those of the population who neglect to maintain a healthy diet and exercise regularly (Rowe & Khan, 1997).
Key social determinants of health that contribute to the overall health status of this population include the extent to which the population is underserved, isolated, and neglected; the extent to which the population has a stable and strong support system; the extent to which the population has friends, family or loved ones who visit and provide social contact for the population, and the extent to which the population is able….....
Dahodwala, N., Siderowf, A., Xie, M., Noll, E., Stern, M., & Mandell, D. S. (2009). Racial differences in the diagnosis of Parkinson\'s disease. Movement Disorders, 24(8), 1200-1205.
Dobkin, R. D., Rubino, J. T., Friedman, J., Allen, L. A., Gara, M. A., & Menza, M. (2013). Barriers to mental health care utilization in Parkinson’s disease. Journal of geriatric psychiatry and neurology, 26(2), 105-116.
Dorsey, E. R., Venkataraman, V., Grana, M. J., Bull, M. T., George, B. P., Boyd, C. M.,... & Biglan, K. M. (2013). Randomized controlled clinical trial of “virtual house calls” for Parkinson disease. JAMA neurology, 70(5), 565-570.
Farombi, T. H., Owolabi, M. O., & Ogunniyi, A. (2016). Falls and Their Associated Risks in Parkinson’s Disease Patients in Nigeria. Journal of movement disorders, 9(3), 160.
Frisina, P. G., Borod, J. C., Foldi, N. S., & Tenenbaum, H. R. (2008). Depression in Parkinson\'s disease: Health risks, etiology, and treatment options. Neuropsychiatric Disease and Treatment, 4(1A), 81-91.
Hatano, T., Kubo, S. I., Shimo, Y., Nishioka, K., & Hattori, N. (2009). Unmet needs of patients with Parkinson\'s disease: interview survey of patients and caregivers. Journal of International Medical Research, 37(3), 717-726.
Jaul, E., & Barron, J. (2017). Age-Related Diseases and Clinical and Public Health Implications for the 85 Years Old and Over Population. Frontiers in public health, 5, 335.
Kleiner-Fisman, G., Gryfe, P., & Naglie, G. (2013). A patient-based needs assessment for living well with Parkinson disease: implementation via nominal group technique. Parkinson’s disease, 2013.
Kowal, S. L., Dall, T. M., Chakrabarti, R., Storm, M. V., & Jain, A. (2013). The current and projected economic burden of Parkinson\'s disease in the United States. Movement Disorders, 28(3), 311-318.
McCormack, A. L., Thiruchelvam, M., Manning-Bog, A. B., Thiffault, C., Langston, J.W., Cory-Slechta, D. A., & Di Monte, D. A. (2002). Environmental risk factors and Parkinson\'s disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat. Neurobiology of disease, 10(2), 119-127.
Michael J. Fox Foundation. (2018). Public policy. Retrieved from https://www.michaeljfox.org/page.html?id=126
Rowe, J. W., & Kahn, R. L. (1997). Successful aging. The Gerontologist, 37(4), 433-440.
Satake, W., Nakabayashi, Y., Mizuta, I., Hirota, Y., Ito, C., Kubo, M., ... & Tomiyama, H. (2009). Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson\'s disease. Nature genetics, 41(12), 1303.
Seidl, S. E., Santiago, J. A., Bilyk, H., & Potashkin, J. A. (2014). The emerging role of nutrition in Parkinson\'s disease. Frontiers in aging neuroscience, 6, 36.
